Risk of T-cell malignancy after CAR T-cell therapy in children, adolescents, and young adults

Blood Adv. 2024 Jul 9;8(13):3544-3548. doi: 10.1182/bloodadvances.2024013243.
No abstract available

Publication types

  • Research Support, N.I.H., Intramural

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Female
  • Humans
  • Immunotherapy, Adoptive* / adverse effects
  • Immunotherapy, Adoptive* / methods
  • Male
  • Receptors, Chimeric Antigen / immunology
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Young Adult

Substances

  • Receptors, Chimeric Antigen